1. Home
  2. ICU
  3. ICU News

Latest SeaStar Medical Holding Corporation (ICU) News on November 25, 2025

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference
ICU

GlobeNewswire

5 days ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

SeaStar Medical Announces Appointment of Michael Messinger as CFO
ICU

GlobeNewswire

8 days ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

ICU

GuruFocus.com

11 days ago

SeaStar Medical Holding Corp (ICU) Q3 2025 Earnings Call Highlights: Revenue Surge and ...

SeaStar Medical (ICU) Q3 2025 Earnings Transcript
ICU

Motley Fool

12 days ago

SeaStar Medical (ICU) Q3 2025 Earnings Transcript

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates
ICU

GlobeNewswire

12 days ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
ICU

GlobeNewswire

13 days ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
ICU

GlobeNewswire

20 days ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

ICU

MT Newswires

5 months ago

Top Midday Gainers

SeaStar Medical Reports Update on Nasdaq Listing Status
ICU

GlobeNewswire

5 months ago

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy
ICU

GlobeNewswire

5 months ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

ICU

MT Newswires

5 months ago

Sector Update: Health Care

ICU

MT Newswires

5 months ago

Top Midday Decliners

ICU

MT Newswires

5 months ago

SeaStar Medical Prices Offering to Raise Up to $8 Million

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering
ICU

GlobeNewswire

5 months ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research
ICU

GlobeNewswire

5 months ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick
ICU

Leasing Life

6 months ago

Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick

BP, EOG achieve first gas from Mento field, offshore Trinidad
ICU

Offshore Technology

6 months ago

BP, EOG achieve first gas from Mento field, offshore Trinidad

Macron urges Asia, Europe to unite to resist 'spheres of coercion'
ICU

AFP

6 months ago

Macron urges Asia, Europe to unite to resist 'spheres of coercion'

Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner
ICU

Footwear News

6 months ago

Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner

ICU

Business Wire

6 months ago

Form 8.3 - American Axle & Manufacturing Holdings, Inc.

Ulta Stock Jumps as Beauty Product Spending Continues
ICU

Investopedia

6 months ago

Ulta Stock Jumps as Beauty Product Spending Continues

Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™
ICU

PR Newswire

6 months ago

Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy
ICU

GlobeNewswire

6 months ago

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market
ICU

NewMediaWire

6 months ago

SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy
ICU

GlobeNewswire

6 months ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

ICU

GuruFocus.com

6 months ago

SeaStar Medical Holding Corp (ICU) Q1 2025 Earnings Call Highlights: Revenue Surge and ...

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates
ICU

GlobeNewswire

6 months ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
ICU

GlobeNewswire

6 months ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025
ICU

GlobeNewswire

7 months ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time
ICU

GlobeNewswire

7 months ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
ICU

GlobeNewswire

8 months ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

ICU

Thomson Reuters StreetEvents

8 months ago

Q4 2024 SeaStar Medical Holding Corp Earnings Call

ICU

GuruFocus.com

8 months ago

SeaStar Medical Holding Corp (ICU) Q4 2024 Earnings Call Highlights: Strategic Advances Amidst ...

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
ICU

GlobeNewswire

8 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
ICU

GlobeNewswire

8 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award
ICU

PR Newswire

8 months ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market
ICU

GlobeNewswire

10 months ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market
ICU

GlobeNewswire

10 months ago

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE
ICU

GlobeNewswire

10 months ago

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

Mayo Clinic joins SeaStar Medical for acute kidney injury trial
ICU

Medical Device Network

10 months ago

Mayo Clinic joins SeaStar Medical for acute kidney injury trial

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial
ICU

GlobeNewswire

10 months ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical says FDA approves feasibility study with SCD-ADULT
ICU

TipRanks

10 months ago

SeaStar Medical says FDA approves feasibility study with SCD-ADULT

ICU

MT Newswires

10 months ago

SeaStar Medical Says FDA Approved Study on Selective Cytopheretic Device in Cardiorenal Syndrome

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
ICU

GlobeNewswire

10 months ago

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer
ICU

GlobeNewswire

a year ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
ICU

GlobeNewswire

a year ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
ICU

GlobeNewswire

a year ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
ICU

GlobeNewswire

a year ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
ICU

GlobeNewswire

a year ago

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
ICU

GlobeNewswire

a year ago

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
ICU

GlobeNewswire

a year ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
ICU

GlobeNewswire

a year ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
ICU

GlobeNewswire

a year ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
ICU

GlobeNewswire

a year ago

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
ICU

GlobeNewswire

a year ago

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
ICU

GlobeNewswire

a year ago

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update
ICU

GlobeNewswire

a year ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024
ICU

GlobeNewswire

a year ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial
ICU

GlobeNewswire

a year ago

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers
ICU

GlobeNewswire

a year ago

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

SeaStar hits halfway mark in AKI trial for selective cytopheretic device
ICU

Medical Device Network

a year ago

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis
ICU

GlobeNewswire

a year ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week
ICU

GlobeNewswire

a year ago

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
ICU

GlobeNewswire

a year ago

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities
ICU

GlobeNewswire

a year ago

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
ICU

GlobeNewswire

a year ago

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
ICU

GlobeNewswire

a year ago

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt
ICU

GlobeNewswire

a year ago

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

ICU

MT Newswires

a year ago

Top Premarket Decliners

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update
ICU

GlobeNewswire

a year ago

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s
ICU

GlobeNewswire

a year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

ICU

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

ICU

MT Newswires

a year ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

ICU

MT Newswires

a year ago

SeaStar Medical Treats First Pediatric Patient in Commercial Setting With Kidney Drug

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device
ICU

GlobeNewswire

a year ago

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
ICU

GlobeNewswire

a year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
ICU

GlobeNewswire

a year ago

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

ICU

MT Newswires

a year ago

Sector Update: Health Care

ICU

MT Newswires

a year ago

SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner
ICU

GlobeNewswire

a year ago

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ICU

GlobeNewswire

a year ago

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

ICU

MT Newswires

a year ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

ICU

MT Newswires

a year ago

SeaStar Medical Launching $10 Million Direct Offering -- Shares Fall

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ICU

GlobeNewswire

a year ago

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

ICU

MT Newswires

a year ago

SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device
ICU

GlobeNewswire

a year ago

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
ICU

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology
ICU

GlobeNewswire

a year ago

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
ICU

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
ICU

GlobeNewswire

a year ago

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU

GlobeNewswire

a year ago

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
ICU

GlobeNewswire

a year ago

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

SeaStar Medical Announces 25-for-1 Reverse Stock Split
ICU

GlobeNewswire

a year ago

SeaStar Medical Announces 25-for-1 Reverse Stock Split

Seastar touts positive case studies for selective cytopheretic device
ICU

Medical Device Network

2 years ago

Seastar touts positive case studies for selective cytopheretic device

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
ICU

GlobeNewswire

2 years ago

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
ICU

GlobeNewswire

2 years ago

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
ICU

GlobeNewswire

2 years ago

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
ICU

GlobeNewswire

2 years ago

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference
ICU

GlobeNewswire

2 years ago

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
ICU

GlobeNewswire

2 years ago

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

Share on Social Networks: